Idera Pharmaceuticals, Inc. (IDRA) Posts Narrower than Expected Q1 Loss

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q1 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c